Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease

References

• Gotham A, Brown R, Marsden C. ‘Frontal’ cognitive function in patients with Parkinson's disease ‘on’ and ‘off’ levodopa. Brain. 1988;111(2):299–321.
   PubMed Web of Science ®Google Scholar
• Muslimović D, Post B, Speelman JD, et al. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology. 2005;65(8):1239–1245.
   PubMed Web of Science ®Google Scholar
• Hobson P, Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Mov Disord. 2004;19(9):1043–1049.
   PubMed Web of Science ®Google Scholar
• Pagonabarraga J, Kulisevsky J, Llebaria G, et al. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease. Mov Disord. 2008;23(7):998–1005.
   PubMed Web of Science ®Google Scholar
• Graff MJ, Vernooij-Dassen MJ, Thijssen M, et al. Effects of community occupational therapy on quality of life, mood, and health status in dementia patients and their caregivers: a randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2007;62(9):1002–1009.
   PubMed Web of Science ®Google Scholar
• Santangelo G, Barone P, Abbruzzese G, et al. Validation of the Italian version of Parkinson's disease-cognitive rating scale (PD-CRS). Neurol Sci. 2014;35(4):537–544.
   PubMed Web of Science ®Google Scholar
• Martínez-Martín P, Prieto-Jurczynska C, Frades-Payo B. Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study. Rev Neurol. 2009;49(8):393–398.
   PubMed Web of Science ®Google Scholar
• O'Bryant S, O'Jile J, McCaffrey R. Reporting of demographic variables in neuropsychological research: trends in the current literature. Clin Neuropsychol. 2004;18(2):229–233.
   PubMed Web of Science ®Google Scholar
• Fernández de Bobadilla R, Pagonabarraga J, Martínez-Horta S, et al. Parkinson's disease‐cognitive rating scale: psychometrics for mild cognitive impairment. Mov Disord. 2013;28(10):1376–1383.
   PubMed Web of Science ®Google Scholar
• Koevoets EW, Schmand B, Geurtsen GJ. Accuracy of two cognitive screening tools to detect mild cognitive impairment in Parkinson's disease. Mov Disord Clin Pract. 2018;5(3):259–264.
   PubMed Web of Science ®Google Scholar
• Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181–184.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370.
   PubMed Web of Science ®Google Scholar
• Ansari NN, Naghdi S, Hasson S, et al. Validation of a Mini-Mental State Examination (MMSE) for the Persian population: a pilot study. Appl Neuropsychol. 2010;17(3):190–195.
   PubMed Web of Science ®Google Scholar
• Ashrafi F, Zali A, Pakdaman H, et al. Cognitive impairments in Parkinson's disease: evidence from an Iranian population. Iran J Neurol. 2012;11(4):151.
   PubMedGoogle Scholar
• Asl AM, Mehdizadeh M, Roudbari PR, et al. Reliability and validity of the Persian version of the clock drawing test in Iranian patients with idiopathic Parkinson's disease. J Clin Physiother Res. 2018;3(2):78–81.
   Google Scholar
• Badrkhahan SZ, Sikaroodi H, Sharifi F, et al. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson’s disease. Appl Neuropsychol Adult. 2020;27(5):431–439.
   PubMed Web of Science ®Google Scholar
• Fereshtehnejad SM, Naderi N, Rahmani A, et al. Psychometric study of the Persian short-form eight-item Parkinson's disease questionnaire (PDQ-8) to evaluate health related quality of life (HRQoL). Health Qual Life Outcomes. 2014;12:78.
   PubMed Web of Science ®Google Scholar
• Khalaji H, Bahramy A, Noroozian M, et al. The effect of physical activity on functional fitness and quality of life in people with Parkinson's disease. Med J Mashhad Univ Med Sci. 2014;57(3):542–554.
   Google Scholar
• Mahmoudi Asl A, Mehdizadeh M, Raeesi Roudbari P, et al. Staging of cognitive impairment in Parkinson’s disease: validity of quick dementia rating system. Disabil Rehabil. 2020. DOI:https://doi.org/10.1080/09638288.2020.1755728
   Google Scholar
• Sadeghi N, Noroozian M, Khalaj H, et al. Preliminary validation study of the Persian version of clinical dementia rating (P-CDR). Zahedan J Res Med Sci. 2011;13(3):20–24.
   Google Scholar
• Santangelo G, Lagravinese G, Battini V, et al. The Parkinson's Disease-Cognitive Rating Scale (PD-CRS): normative values from 268 healthy Italian individuals. Neurol Sci. 2017;38(5):845–853.
   PubMed Web of Science ®Google Scholar
• Serrano-Dueñas M, Serrano M, Villena D, et al. Validation of the Parkinson's Disease-Cognitive Rating Scale applying the Movement Disorder Society Task Force Criteria for Dementia associated with Parkinson's disease. Mov Disord Clin Pract. 2017;4(1):51–57.
   PubMed Web of Science ®Google Scholar
• Woodford H, George J. Cognitive assessment in the elderly: a review of clinical methods. QJM. 2007;100(8):469–484.
   PubMed Web of Science ®Google Scholar
• Dalrymple-Alford J, MacAskill M, Nakas C, et al. The MoCA: well-suited screen for cognitive impairment in Parkinson's disease. Neurology. 2010;75(19):1717–1725.
   PubMed Web of Science ®Google Scholar
• Martínez-Martín P, Gil-Nagel A, Gracia LM, et al. Unified Parkinson's disease rating scale characteristics and structure. Mov Disord. 1994;9(1):76–83.
   PubMed Web of Science ®Google Scholar
• Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr. 1997;9(S1):173–176.
   PubMedGoogle Scholar
• Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Young. 1991;41:1588–1592.
   Google Scholar
• Galvin JE. The Quick Dementia Rating System (QDRS): a rapid dementia staging tool. Alzheimer's Dementia. 2015;1(3):249–259.
   Google Scholar
• Mainland BJ, Shulman KI. Clock drawing test. Cognitive screening instruments. Cham: Springer; 2017. p. 67–108.
   Google Scholar
• Isella V, Mapelli C, Morielli N, et al. Diagnosis of possible Mild Cognitive Impairment in Parkinson's disease: validity of the SCOPA-Cog. Parkinsonism Relat Disord. 2013;19(12):1160–1163.
   PubMed Web of Science ®Google Scholar
• Souza DC, Wegner F, Costa LCM, et al. Measurement properties of the Human Activity Profile questionnaire in hospitalized patients. Braz J Phys Ther. 2017;21(3):153–158.
   PubMed Web of Science ®Google Scholar
• Weir JP. Quantifying test–retest reliability using the intraclass correlation coefficient and the SEM. J Strength Condition Res. 2005;19(1):231–240.
   PubMed Web of Science ®Google Scholar
• Chou C-Y, Chien C-W, Hsueh I-P, et al. Developing a short form of the Berg Balance Scale for people with stroke. Phys Ther. 2006;86(2):195–204.
   PubMed Web of Science ®Google Scholar
• Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42.
   PubMed Web of Science ®Google Scholar
• Adler J, Parmryd I. Quantifying colocalization by correlation: the Pearson correlation coefficient is superior to the Mander's overlap coefficient. Cytometry A. 2010;77(8):733–742.
   PubMed Web of Science ®Google Scholar
• Hamilton D, Giesinger J, MacDonald D, et al. Responsiveness and ceiling effects of the Forgotten Joint Score-12 following total hip arthroplasty. Bone Joint Res. 2016;5(3):87–91.
   PubMed Web of Science ®Google Scholar
• Domholdt E. Rehabilitation research: principles and applications. St. Louis: Saunders; 2005.
   Google Scholar
• Reyes MA, Lloret SP, Gerscovich ER, et al. Addenbrooke's Cognitive Examination validation in Parkinson's disease. Eur J Neurol. 2009;16(1):142–147.
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Frades-Payo B, Rodriguez-Blazquez C, et al. Psychometric attributes of Scales for Outcomes in Parkinson's Disease-Cognition (SCOPA-Cog), Castilian language. Rev Neurol. 2007;47(7):337–343.
   Web of Science ®Google Scholar
• Hirsch L, Jette N, Frolkis A, et al. The incidence of Parkinson's disease: a systematic review and meta-analysis. Neuroepidemiology. 2016;46(4):292–300.
   PubMed Web of Science ®Google Scholar
• Wooten G, Currie L, Bovbjerg V, et al. Are men at greater risk for Parkinson's disease than women? J Neurol Neurosurg Psychiatry. 2004;75(4):637–639.
   PubMed Web of Science ®Google Scholar
• Roohani M, Shahidi GA, Miri S. Demographic study of Parkinson's disease in Iran: data on 1656 cases. Iran J Neurol. 2011;10(1–2):19.
   PubMedGoogle Scholar
• Kokabisaghi F. Women's right to health in Iran: domestic implementation of international human rights law. Int J Health Plann Manage. 2019;34(2):501–509.
   PubMed Web of Science ®Google Scholar